11:45 - 13:15     ICC AUDITORIUM

Late Breaking Clinical Trials

Chairs: Johannes F.E. Mann, Munich, Germany
             Ziad Massy, Paris, France

Supportive versus immunosuppressive therapy for progressive IgA nephropathy (STOPIGAN): a randomized, controlled, open-label multicenter trial
Jürgen Floege, Aachen, Germany

CCR2 inhibitor CCX140 effective in phase 2 clinical trial in diabetic nephropathy
Dick De Zeeuw, Groningen, The Netherlands

A long acting intravenous calcimimetic (AMG416) for secondary hyperparathyroidism (SHPT) in haemodialysed patients
John Cunningham, London, UK

VITA-D study: outcome of a 1-year randomized controlled trial to evaluate vitamin D3 supplementation in vitamin D deficient renal transplant patients
Ursula Thiem, Vienna, Austria

Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical
Alexander Zarbock, Münster, Germany

back to the timetable